A national consultation is underway to inform the Medical Research Future Fund (MRFF) – Australian Medical Research and Innovation Priorities for 2020–2022, led by the Australian Medical Research Advisory Board (AMRAB).
The Priorities are considered by the Minister for Health before the Commonwealth Government decides on the disbursement of funding from the MRFF. It is therefore important that the community – patients, clinicians and researchers alike – are engaged in consultation.
The consultation is open to the Australian public, organisations with expertise in health and medical research and innovation, consumer representatives, clinicians and health services managers.
The Australian Clinical Trials Alliance is currently calling on members to participate in the feedback directly or to send them feedback to inform their response on behalf of the clinical trials sector.
Online submissions are due by 7 October 2020. If you wish to provide input on ACTA’s submission, please submit your response on a brief survey by Tuesday 6 October.
If you wish to participate directly, you can do so through the MRFF consultation hub, where you will find the latest consultation guidance paper.